Intermittent dosing drives market growth

Although bisphosphonates are the mainstay of osteoporosis treatment, there is potential for new and innovative products to gain market share.

Products that offer intermittent dosing schedules are highly desirable in the osteoporosis market and can generate big revenues. Such therapies answer the demand from patients and physicians for more convenient delivery mechanisms that increase complia...